Center For Youthful Aging(Sarasota, FL)
诊疗信息
常见问题
Does this clinic offer telehealth?
Please contact the clinic directly for telehealth availability.
Do they accept HSA/FSA?
Please confirm HSA/FSA acceptance directly with the clinic.
诊所简介
Center For Youthful Aging in Sarasota, FL offers hormone replacement therapy, sexual health, and weight loss under cardiologist Thomas Arne, Jr., DO, FACC.
Center For Youthful Aging in Sarasota, Florida, operates under the medical direction of Thomas Arne, Jr., DO, FACC, a board-certified cardiologist and osteopathic physician with fellowship status in the American College of Cardiology. Dr. Arne holds active certifications with the American Society of Internal Medicine, American Osteopathic Association, and American Heart Association, bringing cardiovascular and metabolic expertise to hormone optimization and age management medicine. The clinic focuses exclusively on in-person consultations, allowing for comprehensive physical assessments and individualized treatment planning for patients throughout the Sarasota area seeking evidence-based approaches to hormonal health.
Hormone replacement therapy forms the clinical foundation, with protocols addressing menopause management, andropause, thyroid dysfunction, and age-related hormonal decline. The practice utilizes bioidentical hormone preparations tailored to individual laboratory findings and symptom profiles, with treatment plans that may include testosterone replacement, estrogen-progesterone therapy, thyroid optimization, and DHEA supplementation. Sexual health services address erectile dysfunction, low libido, and age-related sexual performance concerns through hormonal interventions and adjunctive therapies. Weight loss programs integrate hormone optimization with metabolic assessment, recognizing the interplay between insulin sensitivity, thyroid function, cortisol patterns, and body composition changes that occur with aging.
Dr. Arne’s cardiology background informs the clinic’s approach to hormone therapy, particularly regarding cardiovascular risk assessment and monitoring protocols for patients with existing heart conditions or metabolic syndrome. This dual expertise allows for hormone optimization strategies that account for lipid profiles, blood pressure management, and vascular health considerations often overlooked in standard hormone clinics. The osteopathic training further emphasizes whole-person assessment, examining how musculoskeletal health, stress physiology, and lifestyle factors interact with hormonal balance. Patients receive treatment plans grounded in current research, with Dr. Arne maintaining active involvement in medical literature and evidence-based practice standards through his professional society memberships.
The in-person consultation model at Center For Youthful Aging includes detailed medical history review, physical examination, and comprehensive laboratory testing to establish baseline hormone levels, metabolic markers, and cardiovascular risk factors. Follow-up visits allow for treatment adjustments based on symptom response and repeat laboratory values, with monitoring protocols designed to optimize therapeutic outcomes while minimizing potential risks. Patients typically undergo initial assessments lasting 60-90 minutes, during which Dr. Arne reviews previous medical records, current medications, and treatment goals. The Sarasota location serves residents throughout Manatee and Sarasota Counties seeking specialized hormone care from a physician with advanced cardiovascular training.
With a 5.0-star rating across 31 Google reviews, the practice has developed recognition for its research-informed approach and attention to menopausal symptom management. The clinic’s focus on hormone optimization as a medical discipline rather than a cosmetic service distinguishes its practice model, with treatment decisions guided by objective laboratory data, peer-reviewed evidence, and individual patient physiology. Center For Youthful Aging does not offer telehealth services, maintaining that in-person evaluation remains essential for safe and effective hormone therapy initiation and management, particularly given the cardiovascular and metabolic monitoring requirements inherent in this patient population.
